Clinical impact of somatic alterations in prostate cancer patients with and without previously known germline BRCA1/2 mutations: Results from PROREPAIR-A study

dc.conference.dateSEP 19-OCT 18, 2020
dc.conference.titleESMO Virtual Congress
dc.contributor.authorLozano Mejorada, R.
dc.contributor.authorCastro Marcos, E.
dc.contributor.authorAragon, I. M.
dc.contributor.authorThorne, H.
dc.contributor.authorLopez Campos, F.
dc.contributor.authorSanz, A.
dc.contributor.authorAlonso, C.
dc.contributor.authorAnido, U.
dc.contributor.authorJuan Fita, M. J.
dc.contributor.authorGutierrez Pecharroman, A. M.
dc.contributor.authorRamirez-Backhaus, M.
dc.contributor.authorBalmana, J.
dc.contributor.authorChirivella Gonzalez, I.
dc.contributor.authorLlort, G.
dc.contributor.authorRomero Laorden, N.
dc.contributor.authorArevalo Lobera, S.
dc.contributor.authorRubio Briones, J.
dc.contributor.authorPritchard, C. C.
dc.contributor.authorSandhu, S.
dc.contributor.authorOlmos Hidalgo, D.
dc.contributor.authoraffiliation[Lozano Mejorada, R.] Spanish Natl Canc Res Ctr CNIO, Prostate Canc Clin Res Unit, Madrid, Spain
dc.contributor.authoraffiliation[Aragon, I. M.] Spanish Natl Canc Res Ctr CNIO, Prostate Canc Clin Res Unit, Madrid, Spain
dc.contributor.authoraffiliation[Sanz, A.] Spanish Natl Canc Res Ctr CNIO, Prostate Canc Clin Res Unit, Madrid, Spain
dc.contributor.authoraffiliation[Olmos Hidalgo, D.] Spanish Natl Canc Res Ctr CNIO, Prostate Canc Clin Res Unit, Madrid, Spain
dc.contributor.authoraffiliation[Castro Marcos, E.] Hosp Univ Virgen de la Victoria, Med Oncol, Malaga, Spain
dc.contributor.authoraffiliation[Castro Marcos, E.] Inst Invest Biomed Malaga, Malaga, Spain
dc.contributor.authoraffiliation[Thorne, H.] Peter MacCallum Canc Ctr, Med Oncol, Melbourne, Vic, Australia
dc.contributor.authoraffiliation[Sandhu, S.] Peter MacCallum Canc Ctr, Med Oncol, Melbourne, Vic, Australia
dc.contributor.authoraffiliation[Lopez Campos, F.] Hosp Univ Ramon y Cajal, Radiat Oncol Dept, Madrid, Spain
dc.contributor.authoraffiliation[Alonso, C.] Hosp Univ Princesa, Med Oncol Dept, Madrid, Spain
dc.contributor.authoraffiliation[Anido, U.] CHUS Complejo Hosp Univ Santiago de Compostela SE, Med Oncol Dept, Santiago De Compostela, La Coruna, Spain
dc.contributor.authoraffiliation[Juan Fita, M. J.] Fdn Inst Valenciano Oncol, Med Oncol, Valencia, Spain
dc.contributor.authoraffiliation[Gutierrez Pecharroman, A. M.] Hosp Getafe, Pathol, Getafe, Spain
dc.contributor.authoraffiliation[Ramirez-Backhaus, M.] Fdn Inst Valenciano Oncol, Urol Dept, Valencia, Spain
dc.contributor.authoraffiliation[Rubio Briones, J.] Fdn Inst Valenciano Oncol, Urol Dept, Valencia, Spain
dc.contributor.authoraffiliation[Balmana, J.] Vall dHebron Univ Hosp, Dept Med Oncol, Hereditary Canc Genet Grp 4, VHIO, Barcelona, Spain
dc.contributor.authoraffiliation[Chirivella Gonzalez, I.] Hosp Clin Univ Valencia, Med Oncol Dept, Valencia, Spain
dc.contributor.authoraffiliation[Llort, G.] Corp Sanitaria Univ, Hereditary Canc Unit 8, Parc Tauli Sabadell, Barcelona, Spain
dc.contributor.authoraffiliation[Llort, G.] Corp Sanitaria Univ, Barcelona, Spain
dc.contributor.authoraffiliation[Romero Laorden, N.] Hosp Univ Princesa, Med Oncol Dept, Madrid, Spain
dc.contributor.authoraffiliation[Arevalo Lobera, S.] Hosp Donostia, Med Oncol Dept, San Sebastian, Spain
dc.contributor.authoraffiliation[Pritchard, C. C.] Univ Washington, Lab Med, Seattle, WA 98195 USA
dc.contributor.funderCRIS Foundation
dc.contributor.funderProstate Cancer Foundation
dc.contributor.funderPCF Foundation
dc.date.accessioned2025-01-07T15:10:40Z
dc.date.available2025-01-07T15:10:40Z
dc.date.issued2020-09-01
dc.identifier.doi10.1016/j.annonc.2020.08.872
dc.identifier.essn1569-8041
dc.identifier.issn0923-7534
dc.identifier.unpaywallURLhttp://www.annalsofoncology.org/article/S0923753420408683/pdf
dc.identifier.urihttps://hdl.handle.net/10668/26935
dc.identifier.wosID573469100610
dc.issue.number4
dc.journal.titleAnnals of oncology
dc.journal.titleabbreviationAnn. oncol.
dc.language.isoen
dc.organizationSAS - Hospital Universitario Virgen de la Victoria
dc.organizationInstituto de Investigación Biomédica de Málaga - Plataforma Bionand (IBIMA)
dc.page.numberS509-S510
dc.publisherElsevier
dc.rights.accessRightsopen access
dc.titleClinical impact of somatic alterations in prostate cancer patients with and without previously known germline BRCA1/2 mutations: Results from PROREPAIR-A study
dc.typeconference output
dc.type.hasVersionVoR
dc.volume.number31
dc.wostypeMeeting Abstract

Files